FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes-Reference-Cited by-同舟云学术

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes

Published:2023-05 Issue:3 Volume:22 Page:548-559
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

de Poel E.,Spelier S.,Hagemeijer M.C.,van Mourik P.,Suen S.W.F.,Vonk A.M.,Brunsveld J.E.,Ithakisiou G.N.,Kruisselbrink E.,Oppelaar H.,Berkers G.,de Winter de Groot K.M.,Heida-Michel S.,Jans S.R.,van Panhuis H.,Bakker M.^ORCID,van der Meer R.,Roukema J.^ORCID,Dompeling E.,Weersink E.J.M.,Koppelman G.H.^ORCID,Blaazer A.R.^ORCID,Muijlwijk-Koezen J.E.,van der Ent C.K.,Beekman J.M.

Funder

ZonMw

Nederlandse Cystic Fibrosis Stichting

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference40 articles.

1. Drug repositioning: identifying and developing new uses for existing drugs;Ashburn;Nat Rev Drug Disco.,2004

2. Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury;Huang;PLoS Pathog,2020

3. Current state of CFTR modulators for treatment of cystic fibrosis;Despotes;Curr Opin Pharmacol,2022

4. Protocol for application, standardization and validation of the forskolin-induced swelling assay in cystic fibrosis human colon organoids;Vonk;STAR Protoc,2020

5. Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function;de Winter-de Groot;Eur Respir J,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potential of human intestinal organoids: Applications, challenges, and future directions;Life Sciences;2024-09

2. Dolutegravir induces FOLR1 expression during brain organoid development;Frontiers in Molecular Neuroscience;2024-05-17

3. Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast;Respiratory Investigation;2024-05

4. Year in review 2023 – Back to the future;Journal of Cystic Fibrosis;2024-03

5. Uncovering the Relationship Between Genes and Phenotypes Beyond the Gut in Microvillus Inclusion Disease;Cellular and Molecular Gastroenterology and Hepatology;2024